INVESTOR RELATIONS CONTACT: Ralph Giacobbe 860-787-7968 Ralph.Giacobbe@TheCignaGroup.com • Total revenues for the first quarter 2024 were $57.3 billion • 2024 outlook for adjusted income from operations increased to at least $28.40 per share Shareholders' net loss for first quarter 2024 was $0.3 billion, or $0.97 per share, including a non-cash after-tax investment loss of $1.8 billion, or $6.31 per share, related to the impairment of VillageMD equity securities. This compares with shareholders' net income ...

Total revenues for the first quarter 2024 were $57.3 billion Shareholders' net loss for the first quarter 2024 was $0.3 billion, or $0.97 per share Adjusted income from operations1 for the first quarter 2024 was $1.9 billion, or $6.47 per share 2024 outlook2 for adjusted income from operations1,2 increased to at least $28.40 per share BLOOMFIELD, Conn., May 2, 2024  /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported strong first quarter 2024 results reflecting growth across it ...

Investors are always looking for stocks that are poised to beat at earnings season and The Cigna Group (CI) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Cigna is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator ...

The Cigna Group (CI) is set to sustain its earnings beat streak for the first quarter of 2024, the results for which are scheduled to be released on May 2, before the opening bell. Growth in commercial memberships and strengthening performance in Cigna Healthcare and Evernorth businesses are expected to continue driving its results.The combination of these factors, alongside other favorable conditions, is expected to have a positive impact on its stock performance, which has already been surpassing its peer ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style Score ...

In its upcoming report, Cigna (CI) is predicted by Wall Street analysts to post quarterly earnings of $6.17 per share, reflecting an increase of 14.1% compared to the same period last year. Revenues are forecasted to be $56.64 billion, representing a year-over-year increase of 21.9%.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earn ...

Declining youth mental health persists, and many young people receive fragmented care Managing a child's mental health needs significantly impacts working parents, both personally and professionally Opportunity for employers to strengthen approach to family mental health, drive improved health outcomes The Cigna Group announced new, multiyear philanthropic and community engagement program to improve youth mental health BLOOMFIELD, Conn., April 26, 2024 /PRNewswire/ -- Many American children struggling wit ...

High- and low-concentration interchangeable biosimilar will be available, estimated to save individual patients around $3,500 on average per year  Biosimilar price will be about 85% lower than Humira®* BLOOMFIELD, Conn., April 25, 2024 /PRNewswire/ -- In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible patients of its sp ...

BLOOMFIELD, Conn., April 24, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on June 20, 2024 to shareholders of record as of the close of business on June 4, 2024. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solut ...

股价表现 - Cigna (CI) 在最新交易日收盘价为$352.65，较前一日下跌了0.15%[1] 财务预测 - 分析师和投资者将密切关注Cigna即将公布的财报，预计每股收益为$6.17，同比增长14.05%；预计营收为$56.64亿，同比增长21.87%[3] 评级和估值 - CI目前的Zacks Rank为3 (Hold)，在估值方面，CI的Forward P/E比率为12.46，低于行业的15.32[7][8] - CI目前的PEG比率为1.08，与医疗-HMOs行业的平均PEG比率相同[9]